Form 4 for EXEL EXELIXIS, INC.
Accepted 2025-05-30 00:00:00 ET · period of report 2025-05-29 · accession 0000939767-25-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-30 | 2025-05-29 | EXEL | Eckhardt Sue Gail | Dir | A - Grant | $0.00 | +9,812 | 40.2K | +32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-29 | A | A | 9,812 | $0.00 | 40,218 | D | — | — | (F1) Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 29, 2026, subject to the Reporting Person's continuous service through that date. (F2) Includes 40,218 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs. |